New CDC Funding Opportunity: Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus

New CDC Funding Opportunity: CDC-RFA-DD16-1605 Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus

The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2016 funds to establish, enhance, and maintain rapid population-based surveillance of microcephaly and other adverse outcomes (especially central nervous system (CNS) defects) possibly linked to Zika virus infection during pregnancy using an active case-finding methodology; participate in centralized pooled clinical and surveillance data projects; ensure affected infants and families are referred to services; and assess health and developmental outcomes of these children. This aligns with the National Center on Birth Defects and Developmental Disabilities (NCBDDD) performance goal to enhance birth defects surveillance, research, and prevention. This announcement is for non-research activities supported by CDC, i.e., conduct rapid active population-based ascertainment of select major birth defects possibly linked to maternal Zika virus and to use the data for public health action through monitoring, prevention, and intervention.

Funding Opportunity Number: CDC-RFA-DD16-1605

Funding Opportunity Title: Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus

Funding Instrument Type: Cooperative Agreement

Closing Date for Applications:  Jun 24, 2016   Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.

Expected Number of Awards: 50

Estimated Fiscal Year 2016 Funds: Up to $20,000,000

Award Ceiling: $360,000

Award Floor: $100,000

Eligible Applicants:  State, territory, and District of Columbia governments or their bona fide agent

Awards will be made to all eligible applicants at the funding level indicated by the formula criteria in this published FOA.

Priority Group 1: States and territories with observed distribution of Aedes Aegypti mosquito. All successful applicants will receive $200,000 per year. State and territories will receive an additional $80,000 or $160,000 per year based on:

·        Number of annual live births (benchmarked on 2014 live birth data):

·        States with annual livebirths of 100,000 or more will receive an additional $80,000.

·        States with annual livebirths of 200,000 or more will receive an additional $160,000.

Priority Group 2: States with observed distribution of Aedes Albopictus mosquito. All successful applicants will receive $100,000 per year. State and territories will receive an additional $80,000 or $160,000 per year based on:

·        Number of annual live births (benchmarked on 2014 live birth data):

·        States with annual livebirths of 100,000 or more will receive an additional $80,000.

·        States with annual livebirths of 200,000 or more will receive an additional $160,000.

For additional information, go to http://www.grants.gov/custom/viewOppDetails.jsp?oppId=284078 OR

1)      Go to Grants.gov (http://www.grants.gov/).

2)      In the “search” section at the top of the homepage, enter “CDC-RFA-DD16-1605”

 

Recent Stories
Announcing the New Teratology Society Innovator Award

FDA Launches Predictive Toxicology Roadmap

PODCAST: Secrets of the Human Brain Revealed: Development, Disease & the Zika Virus